YAP/TAZ at the Roots of Cancer

Zanconato, Francesca, Cordenonsi, Michelangelo, Piccolo, Stefano·2016·Cancer Cell
DOI 10.1016/j.ccell.2016.05.005

Cites (221)

Items 201–221 of 221

  1. Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
    Woojin Jeong, Sang-Bae Kim, Bo Hwa Sohn et al. · 2014 · PubMed
  2. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis
    Yingwei Li, He Shen, Costa G. Frangou, Nuo Yang, Jin Guo, Bo Xu, Wiam Bshara, Lori A. Shepherd, Qianqian Zhu, Jianmin Wang et al. · 2015 · Cell Cycle
  3. The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
    Y-H. Zhang, B. Li, Lisong Shen, Y. Shen, Xiao‐Dong Chen · 2013 · International Journal of Immunopathology and Pharmacology
  4. Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
    Masahiro Tsujiura, Virginia Mazack, Marius Sudol · 2014 · PLoS ONE
  5. Expression of Yes-associated protein (YAP) in metastatic breast cancer.
    Hye Min Kim, Woo Hee Jung, Ja Seung Koo · 2015 · PubMed Central
  6. Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.
    Lili Su, Wei-xia Ma, Jian-feng Yuan · 2012 · PubMed
  7. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells
    Qiang Wang, Zhilin Xu, Qun An · 2014 · Molecular Medicine Reports
  8. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells
    XIA SHENG, Wenbin Li, Delin Wang · 2015 · Molecular Medicine Reports
  9. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
    Keira Joann Herr, Ying‐Hung Nicole Tsang, Joanne Ong, Qiushi Li, Lai Lai Yap, Weimiao Yu, Hao Yin, Roman L. Bogorad, James E. Dahlman, Yee Gek Chan et al. · 2014 · Scientific Reports
  10. The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
    Patrizia Vici, Marcella Mottolese, Laura Pizzuti et al. · 2014 · Oncotarget
  11. Expression of Yes-Associated Protein in Cervical Squamous Epithelium Lesions
    Hong Xiao, Lina Wu, Huixia Zheng, Ning Li, Huili Wan, Gang Liang, Yanglu Zhao, Jianfang Liang · 2014 · International Journal of Gynecological Cancer
  12. Correlation of expression of phosphorylated and non-phosphorylated Yes-associated protein with clinicopathological parameters in esophageal squamous cell carcinoma in a Korean population.
    Min‐Kyung Yeo, Seok‐Hyung Kim, Jin‐Man Kim, Songmei Huang, Miran Kim, Kyu Sang Song, Kyung‐Hee Kim · 2012 · PubMed
  13. In melanoma, H ippo signaling is affected by copy number alterations and YAP 1 overexpression impairs patient survival
    Moritz Menzel, Diana Meckbach, Benjamin Weide, Nora C. Toussaint, Karin Schilbach, Seema Noor, Thomas Eigentler, Kristian Ikenberg, Christian Busch, Leticia Quintanilla‐Martínez et al. · 2014 · Pigment Cell & Melanoma Research
  14. Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas
    Alizée Boin, Anne Couvelard, Christophe Couderc, Isabel Brito, Dan Filipescu, Michel Kalamarides, Pierre Bédossa, Leanne de Koning, Carine Danelsky, Thierry Dubois et al. · 2014 · Neuro-Oncology
  15. TAZIs Highly Expressed in Gastric Signet Ring Cell Carcinoma
    Guofeng Yue, Xia Sun, Ana A. Giménez-Capitán · 2014 · BioMed Research International
  16. Eradicating tumor drug resistance at its YAP‐biomechanical roots
    Francesca Zanconato, Stefano Piccolo · 2015 · The EMBO Journal
  17. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
    Laura Romero‐Pérez, Pablo García‐Sanz, Alba Mota et al. · 2015 · Modern Pathology
  18. Differential expression of Yes-associated protein and phosphorylated Yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma.
    Donghoon Kim, Seok-Hyung Kim, Ok-Jun Lee · 2013 · PubMed
  19. Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness
    Kuniaki Tanahashi, Atsushi Natsume, Fumiharu Ohka, Kazuya Motomura, Adiljan Alim, Ichidai Tanaka, Takeshi Senga, Ichiro Harada, Ryuichi Fukuyama, Naoyuki Sumiyoshi et al. · 2015 · Journal of Neuropathology & Experimental Neurology
  20. Yes-associated protein is not an independent prognostic marker in breast cancer.
    Shyr‐Ming Sheen‐Chen, Chun Huang, Ching Hua Tsai · 2012 · PubMed
  21. Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo
    Xingrong Lu · 2012 · Oncology Reports